Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: Efficacy and Safety of HDM1005 Compared to Tirzepatide in Obese Adults Without Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of HDM1005 compared with tirzepatide in adults with obesity without diabetes and is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HDM1005
  • Tirzepatide (tirzepatide)

Snippet

Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Conditions: Obesity | Phase 2 | Status: RECRUITING